ARTIFICIAL LUNG MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026-2033)
Segmentation
By Product TypeExtracorporeal Membrane Oxygenation (ECMO) Systems (Veno-Arterial (VA) ECMO, Veno-Venous (VV) ECMO) · Paracorporeal Artificial Lungs (Pumpless Paracorporeal Devices, Pump-Assisted Paracorporeal Devices) · and Implantable Artificial Lungs (Intrathoracic Devices, Others (Oxygenators)) · By Technology (Perfusion Systems, Membrane Oxygenation Technology, Microfluidic Oxygenators, Biohybrid Systems, Pumpless Gas Exchange Systems, and Others (3D-Printed Artificial Lung Constructs, etc.)) · By Portability (Stationary Systems, Portable Systems, and Wearable Systems) · By Application (Lung Transplant Support (Bridge-to-Transplant), Acute Respiratory Distress Syndrome (ARDS), Chronic Respiratory Conditions (COPD), Pulmonary Hypertension, Cystic Fibrosis) · and Others (Coronary Artery Bypass Grafting, etc.)
By Patient TypeNeonates · Pediatric · and Adult
By End UserHospitals · Transplant Centers · Ambulatory Surgical Centers · Emergency and Trauma Centers · Home Care Settings (for wearable devices) · and Others (Research Institutes, etc.)
By GeographyNorth America · Latin America · Europe · Asia Pacific · Middle East & Africa
Published In11 Mar 2026
Report CodeCMI8255
Pages250+
FormatsExcel and PDF
Base Year2025
Estimated Year2026
Historical Range2020 - 2024
Forecast Period2026-2033
Market Segmentation
Product Type Insights (Revenue, USD Bn, 2021 - 2033)
Extracorporeal Membrane Oxygenation (ECMO) Systems
